ME/CFS Research Foundation Logo

National Clinical Studies Group (NKSG)

About

Country:
Germany
Sponsors:

 

Research types:
Clinical research

Link

Website

Description

The National Clinical Studies Group (NKSG), funded by the Federal Ministry for Education and Research (BMBF), is an interdisciplinary network of physicians and scientists with the aim of conducting translational research and therapy studies for the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Post-COVID-19 Syndrome (PCS). The NKSG is conducting initial clinical trials of drugs and medical procedures for PCS and ME/CFS. The aim is to test therapeutic approaches and, if they are effective, to get them approved quickly so that they are available to all patients. The focus lies on the application of drugs that are already approved for other diseases. Preparing and conducting clinical trials has become very time-consuming and expensive. In this context, the study group benefits from the expertise of the Charité Clinical Trial Office. In the first studies, three drugs/medical devices are initially being tested. Interventions are directed against inflammation, circulatory disorders and autoantibodies - these are antibodies that attack certain endogenous structures. Clinical trials are accompanied by a comprehensive biomarker and diagnostics program to investigate relevant biomarkers for the pathomechanisms of the diseases, determined via drawing samples from patients before and after treatment, and to better understand the mode of action of the various therapies. Diagnostics also include modern high-throughput sequencing at the single-cell level, which is carried out and analyzed by the German Center for Neurodegenerative Diseases (DZNE). In addition to developing tests that can predict treatment response, the aim is to develop specific diagnostic tests for ME/CFS and PCS. In the diagnostics platform, brain function is examined using functional MRI, accompanyied by arterial spin labeling (ASL), and vascular function by using endothelial peripheral arterial tonometry (EndoPAT), optical coherence tomography angiography (OCT-A) and non-invasive dynamic vessel analysis (DVA). Description adapted from research network website: see link above.
Research projects
11
Research areas
19
Research types
4
Working groups
14
People
20
Publications
4

Research projects

Analysis of Blood Immune Cell Transcriptomes by Single-Cell RNA Sequencing (scRNA-seq)
Project status:
Ongoing
Country:
Germany
Principal investigator:
Anna Aschenbrenner
Organisations:
Charité – University Medicine Berlin, University Clinic Bonn, German Center for Neurodegenerative Diseases (DZNE)
Research period:
2022-10
to not available
Research types:
Clinical research
Research areas:
Hemic and lymphatic system dysfunction, General
Analysis of Differences in Plasma Proteins Using Mass Spectrometry
Project status:
Ongoing
Country:
Germany
Principal investigator:
Markus Ralser
Organisations:
Charité – University Medicine Berlin
Research period:
2022-10
to not available
Research types:
Clinical research
Research areas:
General
Analysis of Serum/Plasma Markers and Changes in Cellular Composition and Activation of Blood Cells
Project status:
Ongoing
Country:
Germany
Principal investigator:
Birgit Sawitzki
Organisations:
Charité – University Medicine Berlin, Berlin Institute of Health at Charité (BIH)
Research period:
2022-10
to not available
Research types:
Clinical research
Research areas:
General
Endothelial Peripheral Arterial Tonometry (EndoPAT)
Project status:
Ongoing
Country:
Germany
Principal investigator:
Carsten Finke
Organisations:
Charité – University Medicine Berlin, Berlin School of Mind and Brain
Research period:
2022-10
to not available
Research types:
Clinical research
Research areas:
Cardiovascular system dysfunction
Hyperbaric High Pressure Oxygen Therapy (HBOT) in Post-COVID Syndrome and ME/​CFS
Project status:
Ongoing
Country:
Germany
Principal investigator:
Carmen Scheibenbogen
Organisations:
Charité – University Medicine Berlin
Research period:
2023-07
to 2025-08
Research types:
Clinical research
Research areas:
Nervous system dysfunction, Cardiovascular system dysfunction
Immunoadsorption in Patients With Chronic Fatigue Syndrome Including Patients With Post-COVID-19 CFS (IA-PACS-CFS)
Project status:
Ongoing
Country:
Germany
Principal investigator:
Harald Pruess
Organisations:
Charité – University Medicine Berlin, German Center for Neurodegenerative Diseases (DZNE)
Research period:
2023-10
to 2025-02
Research types:
Clinical research
Research areas:
Immune system dysfunction
Methylprednisolone in Patients With Cognitive Deficits in Post-COVID-19 Syndrome (PCS) (PoCoVIT)
Project status:
Ongoing
Country:
Germany
Principal investigator:
Christiana Franke
Organisations:
Charité – University Medicine Berlin
Research period:
2023-10
to 2025-03
Research types:
Clinical research
Research areas:
Immune system dysfunction, Nervous system dysfunction
Optical Coherence Tomography Angiography (OCT-A) and Non-invasive Dynamic Vessel Analysis (DVA)
Project status:
Ongoing
Country:
Germany
Principal investigator:
Carsten Finke
Organisations:
Charité – University Medicine Berlin, Berlin School of Mind and Brain, Max Delbrück Center (MDC)
Research period:
2022-10
to not available
Research types:
Clinical research
Research areas:
Cardiovascular system dysfunction
Repeat Immunoadsorption Post Covid ME/​CFS (RIA)
Project status:
Ongoing
Country:
Germany
Principal investigator:
Carmen Scheibenbogen
Organisations:
Charité – University Medicine Berlin
Research period:
2022-08
to 2025-01
Research types:
Clinical research
Research areas:
Immune system dysfunction
Structural and Functional MRI Studies and Accompanying Arterial Spin Labeling (ASL)
Project status:
Ongoing
Country:
Germany
Principal investigator:
Carsten Finke
Organisations:
Charité – University Medicine Berlin, Berlin School of Mind and Brain, Max Delbrück Center (MDC)
Research period:
2022-10
to not available
Research types:
Clinical research
Research areas:
Nervous system dysfunction, Cardiovascular system dysfunction
Study to Investigate Improvement in Physical Function in SF-36 With Vericiguat Compared With Placebo in Participants With Post-COVID-19 Syndrome (VERI-LONG)
Project status:
Ongoing
Country:
Germany
Principal investigator:
Judith Bellmann-Strobl
Organisations:
Charité – University Medicine Berlin, Max Delbrück Center (MDC)
Research period:
2023-06
to 2025-04
Research types:
Clinical research
Research areas:
Cardiovascular system dysfunction